BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut

BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut

Source: 
Xconomy
News Tags: 
snippet: 

Rare disease drug developer BridgeBio is now a public company, raising $348.5 million in the biggest biotech IPO so far this year.